Date & Time of Session - 3/9/26 - from 12:00 - 1:00 PM

Overview
Myasthenia gravis (MG) is a complex neuromuscular disorder that requires thoughtful medication management. Careful selection of medications is required when treating a patient with myasthenia gravis, so not to exacerbate their current condition, but to also treat their symptoms and improve quality of life. Understanding which medications to avoid, when to use IVIG or plasma exchange, and how to optimize chronic regimens is essential for improving patient outcomes. Additionally, new therapeutic agents and targets have recently been identified, shifting how these patients are chronically managed. Identification of these newer agents, as well as understanding how to manage patients with myasthenia gravis in both an inpatient and outpatient setting, is crucial for pharmacists to optimize patient care. Reviewing current evidence for management and newly approved medication options for treatment will aid in clinical decision-making and support safer medication administration overall. 

Objectives
Upon completion of this activity, participants will be able to:
1. Describe the epidemiology and pathophysiology of myasthenia gravis.
2. Identify medications that may exacerbate myasthenia gravis symptoms.
3. Evaluate acute and chronic therapeutic management of myasthenia gravis.

Target Audience
Free 1 credit hour of Continuing Education for St Elizabeth Health Care providers, Pharmacists, Residents and Students

Special Services
If you require special assistance to attend this event, please call Deanna Fliehman at (859) 301-6191

Speaker
Lauren Krausen, PharmD
PGY1 Pharmacy Resident 
St Elizabeth Healthcare - Edgewood, Kentucky

Session date: 
03/09/2026 - 12:00pm EDT to 05/07/2026 - 11:59pm EDT
Location: 
St. Elizabeth Healthcare
1 Medical Village Drive
Edgewood, KY 41017
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-9999-26-007-L01-P

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Lauren Krausen, PharmD

has no relevant financial relationships to disclose at this time.